Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Gross Margin
Tanvex BioPharma Inc

24.2%
Current
11%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
24.2%
=
Gross Profit
8.4m
/
Revenue
34.6m

Gross Margin Across Competitors

Country KY
Market Cap 11.2B TWD
Gross Margin
24%
Country US
Market Cap 333B USD
Gross Margin
67%
Country US
Market Cap 172.6B USD
Gross Margin
63%
Country US
Market Cap 128.7B USD
Gross Margin
86%
Country US
Market Cap 110.9B USD
Gross Margin
87%
Country US
Market Cap 108.9B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 145.3B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38B USD
Gross Margin
87%
Country KY
Market Cap 250.9B CNY
Gross Margin
84%

Profitability Report

View the profitability report to see the full profitability analysis for Tanvex BioPharma Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
24.2%
=
Gross Profit
8.4m
/
Revenue
34.6m
What is the Gross Margin of Tanvex BioPharma Inc?

Based on Tanvex BioPharma Inc's most recent financial statements, the company has Gross Margin of 24.2%.